On-demand Streaming is available! (Digest version of highlight programs) APASL STC 2025 Tokyo offer on-demand streaming from December 2025 for two months. You can watch the highly informative “State-of-the-Art Lectures”, highlight talks by renowned researchers, Symposiums, Workshops, and Plenary Session. General price to watch: US$50 Please go to the Online Registration https://app.payvent.net/embedded_forms/show/690addf20da6f926908909fd *If you have already registered for APASL STC 2025 Tokyo, there is no additional charge. The information for On-demand Streaming will be sent by email. *APASL members can view the event for free. We will direct you to the member page. The information for On-demand Streaming will be sent by email. Enjoy the Video Streaming of APASL STC … [Read more]

Please check out the latest scientific program of APASL STC 2025 Yangon !! We hope you all immerse yourself in the rich heritage and timeless beauty of Myanmar !! Scientific Program

APASL STC 2025 Pakistan will be held on December 5-7 !! Why don’t you conclude this year with our conference with insightful sessions !! https://apaslstc2025pakistan.com/

Congratulations !! Professor Masao Omata was awarded APDWF Meritorious Award at APDW 2025 Singapore !! We would like to extend our heartfelt congratulations to Professor Omata for his great achievements and contributions for the development of Hepatology over the decades, and sincerely wish him ever-increasing success and prosperity! Professor George Lau respectfully read citation as below. https://www.apasl.info/wp-apasl/wp-content/uploads/2025/11/Masao-Omata_citation_20_11_2025-1.pdf

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This research highlights a promising step toward achieving a functional cure for chronic hepatitis B through targeted immunomodulation. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10917-0 #HepatitisB#HBVResearch#Immunotherapy#Hepatology#LiverDisease#Bepirovirsen#HepatologyInternational#ViralHepatitis#ClinicalResearch#HealthcareProfessionals

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), underscoring the complex interplay between mental health and metabolic liver disease. This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10922-3 #MASLD#LiverHealth#Depression#MentalHealth#Hepatology#MetabolicDisease#HepatologyInternational#LiverResearch#PublicHealth#HealthcareProfessionals

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), underscoring the complex interplay between mental health and metabolic liver disease. This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10922-3 #MASLD#LiverHealth#Depression#MentalHealth#Hepatology#MetabolicDisease#HepatologyInternational#LiverResearch#PublicHealth#HealthcareProfessionals

Understanding the stage-specific impact of portal hypertension is crucial in optimizing surgical outcomes for hepatocellular carcinoma (HCC). This study provides valuable insights into how portal hypertension influences prognosis and postoperative outcomes following liver resection, emphasizing the importance of individualized treatment strategies. Read the full article here: https://link.springer.com/article/10.1007/s12072-025-10879-3 #Hepatology#LiverSurgery#HCC#PortalHypertension#LiverResection#HepatologyInternational#LiverCancer#ClinicalResearch#Oncology#Hepatobiliary

Please check out the Scientific Program of APASL STC 2025 Yangon scheduled on December 13-14 !! We are so thrilled to welcome you in the beautiful city of Yangon !! Scientific Program – APASL – SINGLE TOPIC CONFERENCE 2025, YANGON

APASL STC 2025 Pakistan will be held on December 5-7 !! Please check out its details from the following URL !!

APASL STC 2025 Qingdao scheduled on November 1-2 is just around the corner !! We look forward to your active involvement !!

Discover new insights into the immune landscape of chronic hepatitis B through this study on B-cell subset heterogeneity in the liver. The findings enhance understanding of immune regulation and its implications for disease progression and therapeutic strategies in HBV infection. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10930-3 #HepatitisB#LiverImmunology#HepatologyResearch#ChronicHBV#BCells#HepatologyInternational#LiverScience#MedicalResearch#HealthcareProfessionals

APASL Oncology 2026 Tokyo will be held in Tokyo on April 2-3, 2026 !! Abstract Submission is available until December31, 2025 form the following URL !! https://www.apasl-oncology2026tokyo.org/abs.html We are waiting for your submission !!

APASL Hepatology Webinar 9-3 Highlight of “Hepatology International ” will be held on September 26 !! With the theme of ACLF& Others, we are glad to hold a fulfilling webinar with eminent panelists, moderators and speakers !!

Please check our the latest information about APASL 2026 Istanbul !! https://www.apasl2026istanbul.org/ We are waiting for your participation !!

We plan to hold TWO STCs in January in Delhi, India. We are so excited to welcome you to the fulfilling conferences !!

Please check out the details of APASL STC 2026 New Delhi !! We look forward to your participation !!

APASL STC 2025 Moscow is changing its format to online !! We look forward to your active participation !!